Account:
Ottawa, Canada, January 17, 2012 – Sussex Research Laboratories Inc. announced today that Professor Christopher N. Boddy of the University of Ottawa has received an NSERC Engage grant for a project entitled Development of a process for the manufacture of pseudaminic acid.
Pseudaminic acid, a sialic acid (neuraminic acid) analogue, represents a promising new class of bacterial sugars with relevance in medicine and biology. Pseudaminic acid containing glycoconjugates are thought to influence pathogenesis through bacterial adhesion, invasion, and immune evasion, and are associated with bacterial cell surface structures such as lipopolysaccharide, capsular polysaccharide, pili and flagella. However, there is no cost-effective method available for the production of this rare sugar.
According to Brady Clark, President & CEO of Sussex Research, “As industrial partner on the project, Sussex Research is very pleased to support Professor Boddy and his research team. The Boddy laboratory are experts in metabolic engineering and have a track record of developing manufacturing processes at the research level, including the development of a commercial fermentation-based process for the production of sialic acid. This collaboration will extend the ability of Sussex Research to make pseudaminic acid available in larger quantities and at reasonable cost to researchers worldwide.”
Development of a fermentation-based process for the manufacture of pseudaminic acid requires metabolic engineering to optimize the production strain and development of an efficient low cost isolation procedure. The Boddy group has been and will continue to work in collaboration with Ian Schoenhofen of the National Research Council (NRC) of Canada, who previously developed the in vitro enzymatic methodology for pseudaminic acid production at milligram scales.
About Sussex Research: Sussex Research is a well known specialist in carbohydrate synthesis and associated methodology development. As a carbohydrate-enabling company with an established international reputation, Sussex Research excels in the design, synthesis and characterization of carbohydrate-based molecules. The company’s unique product portfolio and custom synthesis service enables researchers across a wide variety of scientific research disciplines to readily explore and exploit carbohydrates and carbohydrate modified molecules such as glycoamino acids, glycopeptides, oligosaccharides, special carbohydrate linker/spacer systems and other glycoconjugates in numerous and diverse applications. For more information visit www.sussex-research.com.
SHARE THIS ARTICLE ON:
Get product updates and announcements from Sussex Research in your inbox at no charge.
Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California
September 15, 2023
Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan
August 14, 2023
Sussex Research Laboratories Inc. Welcomes Dr. Nycholat as New CSO and Director of U.S. Subsidiary in San Diego
July 14, 2023
Sussex Research Laboratories Inc. Official Sponsor of Glyconet's Canadian Glycomics Symposium 2023
May 11, 2023
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics
April 27, 2023